“Although more evidence is needed before changing clinical practice, these are highly promising results, suggesting that (Bavencio) could prevent patients with chemo-resistant disease from the severe toxicity of chemotherapy combinations.”
An expert discusses the exciting new developments extending survival in the evolving ovarian cancer treatment space.
New Initiative Aims to Foster Informed Discussions Between Newly Diagnosed Lung Cancer Patients, Caregivers and Their Healthcare Team
I am privileged and honored to nominate Miami Cancer Institute (MCI) pediatric oncology nurse Alicia De Pazos, RN, CPHON, for the 2019 CURE® Extraordinary Healer® Award. Alicia has been a pediatric oncology nurse for over 32 years. In that time, she has held many different positions — all in the pediatric oncology setting.
One oncology nurse developed the BARF scale so her young patients could better communicate how they were feeling.
The combination of Calquence and Rituxan may also be useful during the COVID-19 pandemic as it decreases infusion times and patient interactions, according to an expert.
Fundraising to fight cancer is flourishing in Second Life, a virtual world where peopl's created characters live an alternative "life"
Over the past few decades, prostate cancer has become better understood and treated more effectively.
Nubeqa and ADT treatment led to positive impacts on health-related quality of life vs placebo in metastatic hormone-sensitive prostate cancer.
After nearly 30 years with cancer — community, research and education have helped us find hope, strength and purpose in the face of chronic blood cancers.
Sometimes in life, we are fortunate enough to meet an individual who inspires us, motivating us to be our best. I was fortunate to meet Valerie “Val” Betancourt, M.S.N., RN, NP-C, OCN, over 20 years ago. Little did I know this was going to be the beginning of a wonderful friendship.
Bonnie Joyce Blankert, caregiver and 2016 MPN Hero, discusses the importance of remaining calm when caregiving for a loved one with MPN who recently had a stem cell transplant.
Renee Cowan, gynecologic oncology fellow at Memorial Sloan Kettering Cancer Center (MSK), discusses the importance of patients with ovarian cancer seeing an oncologist who specializes in the field.
Lisa Richardson, M.D., M.P.H., director of the Centers for Disease Control and Prevention's (CDC) Division of Cancer Prevention and Control, discusses the CDC's role in the National Cancer Moonshot Initiative.
Amanda Yopp, NP, Clinical Nurse Educator, Takeda Oncology, discusses educating patients before they enroll on a clinic trial.
I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still searching for peace.
An Extraordinary Healer essay honoring JESSICA KOBS, RN [AMERICAN FAMILY CHILDREN’S HOSPITAL, PEDIATRIC ONCOLOGY, MADISON, WISCONSIN]
Dr. Aman Buzdar discusses the latest breast cancer treatment strategies with aromatase inhibitors.
An Extraordinary Healer essay honoring CAROL J. STALZER, B.S.N., RN, CBCN [UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, HOUSTON, TEXAS]
An Extraordinary Healer essay honoring Sarah Rowe, RN, OCN [ Florida Cancer Affiliates in Panama City, Florida ]
Stomach cancer non-profit organization hosts "Hereditary Diffuse Gastric Cancer: The past, the present, and hope for the future" event.
It is that one-to-one communication that allows Kimberly Rosencrance, B.S.N., RN, OCN, to excel as an oncology nurse.
An Extraordinary Healer essay honoring Kim-Chi Pham, RN, OCN [Harris Health System – Lyndon B. Johnson General Hospital in Houston, Texas]
The Chan Zuckerberg Initiative (CZI) announced that the Fibrolamellar Cancer Foundation (FCF) is among a select group of patient-led rare disease organizations, including rare cancer foundations, to receive the first CZI Rare As One Network grant.
Being a cancer survivor for nine and a half years has taught me to live in the moment, to make those moments count.
At a median follow-up of almost two years, 88.5% of patients remained on study treatment.
Lung cancer registries, like the Bonnie J. Addario Lung Cancer Foundation's, can be beneficial to patients and researchers.
Clinical genetics experts see value in testing more women for BRCA mutations.